BBDTXBlack Diamond Therapeutics Inc

Black Diamond Therapeutics Inc

BDTX

$1.70-4.24%

Delayed · as of Oct 13, 2026, 11:15 AM ET

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive BDTX chart

  • Mkt cap

    $95.69M

  • EV/Sales

    1.07

  • P/E ratio

    N/A

  • FY2025 Revenue

    $70.00M

  • EPS (H1 2026)

    $-0.33

  • Gross Margin (FY2025)

    N/A

  • Profit Margin (FY2025)

    31.95%

  • Beta

    N/A

  • Div yield

    N/A

  • Sector

    Healthcare

No recent filings in cache.

Live BDTX terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

BDTX — Black Diamond Therapeutics Inc · rev $70.0M

BDTX Key Statistics

  • Market Cap: $95.7M
  • P/B Ratio: 0.91
  • Previous Close: $1.77
  • Volume: 170,112
  • Day Range: $1.70 – $1.76

Black Diamond Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full BDTX income, balance, and cash tables.

  • Revenue$70.0M
  • Net Income$22.4M
  • Total Assets$143.0M

BDTX FAQ

What industry is BDTX in?

Black Diamond Therapeutics Inc (BDTX) is a biotechnology company in the Healthcare sector.

What are BDTX's latest revenue and net income?

Latest cached Black Diamond Therapeutics Inc (BDTX) revenue for Dec 31, 2025 was $70.0M. Net income was $22.4M. Statements: https://lician.com/financials/bdtx

What is BDTX's market cap?

Black Diamond Therapeutics Inc (BDTX) market capitalization is $95.7M on the latest cached snapshot.

What are BDTX's previous close, day range, and volume?

Black Diamond Therapeutics Inc (BDTX) cached previous close $1.77; day range $1.70 – $1.76; volume 170,112. Session quote: https://lician.com/quote/bdtx

Live BDTX terminal loads when you scroll near this section.